Retham Technologies, Inc.
PrivateLast Round
Seed
Sep 11, 2026
Total Funding Raised
$2.07M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Retham Technologies, Inc. is a biotechnology company that develops in vitro diagnostic assays for the diagnosis and management of heparin-induced thrombocytopenia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Retham Technologies, Inc. Comparables
Compare Retham Technologies, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cryopep | 77% | |
| Sysmex Corporation | 73% | |
| Hart Biologicals | 72% |
Retham Technologies, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 11, 2026 | ||||
| Grant | Dec 19, 2023 | ||||
| Seed | Dec 16, 2020 |
Key People
Founding team and executive leadership
Retham Technologies, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Golden Angels Investors | Seed |
| Wisconsin Economic Development Corporation | Seed, Grant |
| Milwaukee Venture Partners | Seed |
| BrightStar Wisconsin Foundation | Seed |
| Talents Fund Capital Management | Seed |
| Center for Technology Commercialization | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
$1.06M raised in Seed Round.
- Jul 26, 2026
Monthly visitors grew 413% MoM, from 223 to 1.1K.
Recent news
Latest coverage and updates
- receives_financingSep 15, 2026
Retham Technologies, Inc. received financing of $1.5M in Seed on Sep 15th '26.
Retham Technologies, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Retham Technologies, Inc.'s valuation, stock price, and market status.
Is Retham Technologies, Inc. a public or private company?
Retham Technologies, Inc. is a private company.
What is the current stock price of Retham Technologies, Inc.?
Retham Technologies, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Retham Technologies, Inc. worth (valuation)?
Valuation information for Retham Technologies, Inc. is not publicly available.
Can I buy Retham Technologies, Inc. stock?
Retham Technologies, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Retham Technologies, Inc.'s last funding round?
Retham Technologies, Inc.'s most recent funding round was Grant on December 19, 2023.
Who are the main investors in Retham Technologies, Inc.?
Key investors in Retham Technologies, Inc. include Wisconsin Economic Development Corporation, BrightStar Wisconsin Foundation, Center for Technology Commercialization, National Institutes of Health (NIH).
Will Retham Technologies, Inc. IPO soon?
No public IPO plans have been announced for Retham Technologies, Inc..
How can I track Retham Technologies, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Retham Technologies, Inc.'s secondary market activity and sign up for updates.